Predictors and clinical significance of local recurrence in extremity soft tissue sarcoma. 2013

Vignesh K Alamanda, and Samuel N Crosby, and Kristin R Archer, and Yanna Song, and Herbert S Schwartz, and Ginger E Holt
Department of Orthopaedics and Rehabilitation, Vanderbilt University Medical Center, Nashville, Tennessee 37232-8774, USA.

BACKGROUND Limb salvage surgery (LSS) has gained widespread acceptance as the current treatment for treating extremity soft tissue sarcoma (STS) and has been greatly refined since its inception. Combined with improved adjuvant treatment modalities, rates of local relapse have greatly decreased. Nonetheless, local recurrence still occurs and identifying the cause and the subsequent effects of local recurrence can provide valuable insights as LSS continues to evolve. METHODS This retrospective study evaluated 278 patients treated for STS of the extremities between 2000 and 2006. Of these, 41 patients developed a local recurrence while 247 did not. Tumor characteristics and prognostic outcomes were analyzed. Wilcoxon rank sum test and either χ(2) or Fisher's exact was used to compare variables. Kaplan Meier and Gray's test for cumulative risk were also performed. RESULTS Patients who had a positive margin were 3.76 times more likely to develop local recurrence when compared to those with negative margins. This corresponds to a 38% risk of local recurrence if the margins were positive after six years vs. 12% if the margins were negative. In patients who underwent a re-excision, the presence or absence of residual disease upon re-excision did not have any bearing on local recurrence (p = 0.27). In comparing patients with and without local recurrence, there was no statistically significant difference in the rate and the proportion encountering distant metastasis and death due to sarcoma (p > 0.05). CONCLUSIONS Despite advancements in surgery, radiation and imaging, positive margins still occur, and the presence of positive margins following definitive treatment continues to remain as a strong predictor for local recurrence. While local recurrence represents a negative outcome for a patient, its impact on future prognosis is influenced by a variety of factors such as time to local recurrence as well as the tumor's inherent biological characteristics.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002423 Cause of Death Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint. Causes of Death,Death Cause,Death Causes
D005121 Extremities The farthest or outermost projections of the body, such as the HAND and FOOT. Limbs,Extremity,Limb
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Vignesh K Alamanda, and Samuel N Crosby, and Kristin R Archer, and Yanna Song, and Herbert S Schwartz, and Ginger E Holt
October 2016, The Surgical clinics of North America,
Vignesh K Alamanda, and Samuel N Crosby, and Kristin R Archer, and Yanna Song, and Herbert S Schwartz, and Ginger E Holt
August 2023, EFORT open reviews,
Vignesh K Alamanda, and Samuel N Crosby, and Kristin R Archer, and Yanna Song, and Herbert S Schwartz, and Ginger E Holt
February 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Vignesh K Alamanda, and Samuel N Crosby, and Kristin R Archer, and Yanna Song, and Herbert S Schwartz, and Ginger E Holt
May 1999, The Australian and New Zealand journal of surgery,
Vignesh K Alamanda, and Samuel N Crosby, and Kristin R Archer, and Yanna Song, and Herbert S Schwartz, and Ginger E Holt
February 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Vignesh K Alamanda, and Samuel N Crosby, and Kristin R Archer, and Yanna Song, and Herbert S Schwartz, and Ginger E Holt
February 1994, Annals of surgery,
Vignesh K Alamanda, and Samuel N Crosby, and Kristin R Archer, and Yanna Song, and Herbert S Schwartz, and Ginger E Holt
January 2022, Expert review of anticancer therapy,
Vignesh K Alamanda, and Samuel N Crosby, and Kristin R Archer, and Yanna Song, and Herbert S Schwartz, and Ginger E Holt
March 1990, Cancer,
Vignesh K Alamanda, and Samuel N Crosby, and Kristin R Archer, and Yanna Song, and Herbert S Schwartz, and Ginger E Holt
February 2020, Current treatment options in oncology,
Vignesh K Alamanda, and Samuel N Crosby, and Kristin R Archer, and Yanna Song, and Herbert S Schwartz, and Ginger E Holt
December 2012, Cancer,
Copied contents to your clipboard!